Tower Bridge Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.14M | Sell |
6,681
-10
| -0.1% | -$10.1K | 0.59% | 52 |
|
|
2025
Q4 | $7.19M | Sell |
6,691
-55
| -0.8% | -$52.6K | 0.73% | 41 |
|
|
2025
Q3 | $5.15M | Sell |
6,746
-75
| -1% | -$55.8K | 0.51% | 53 |
|
|
2025
Q2 | $5.32M | Sell |
6,821
-125
| -2% | -$97.1K | 0.57% | 52 |
|
|
2025
Q1 | $5.74M | Sell |
6,946
-868
| -11% | -$722K | 0.64% | 48 |
|
|
2024
Q4 | $6.03M | Sell |
7,814
-1,335
| -15% | -$1.11M | 0.64% | 45 |
|
|
2024
Q3 | $8.11M | Buy |
9,149
+3,110
| +51% | +$2.8M | 0.84% | 38 |
|
|
2024
Q2 | $5.47M | Sell |
6,039
-62
| -1% | -$49.6K | 0.61% | 48 |
|
|
2024
Q1 | $4.75M | Sell |
6,101
-1,001
| -14% | -$712K | 0.48% | 60 |
|
|
2023
Q4 | $4.14M | Buy |
7,102
+62
| +0.9% | +$36.2K | 0.36% | 75 |
|
|
2023
Q3 | $3.78M | Sell |
7,040
-1
| -0% | -$515 | 0.35% | 76 |
|
|
2023
Q2 | $3.3M | Buy |
7,041
+1,049
| +18% | +$440K | 0.3% | 82 |
|
|
2023
Q1 | $2.06M | Hold |
5,992
| – | – | 0.17% | 112 |
|
|
2022
Q4 | $2.19M | Sell |
5,992
-15
| -0.2% | -$5.32K | 0.18% | 109 |
|
|
2022
Q3 | $1.94M | Sell |
6,007
-45
| -0.7% | -$14.3K | 0.17% | 112 |
|
|
2022
Q2 | $1.96M | Sell |
6,052
-1,690
| -22% | -$507K | 0.16% | 110 |
|
|
2022
Q1 | $2.22M | Buy |
7,742
+1,150
| +17% | +$296K | 0.15% | 115 |
|
|
2021
Q4 | $1.82M | Sell |
6,592
-1,600
| -20% | -$406K | 0.11% | 131 |
|
|
2021
Q3 | $1.89M | Buy |
8,192
+816
| +11% | +$201K | 0.13% | 126 |
|
|
2021
Q2 | $1.69M | Buy |
7,376
+2,213
| +43% | +$445K | 0.11% | 127 |
|
|
2021
Q1 | $965K | Buy |
5,163
+1,300
| +34% | +$254K | 0.07% | 142 |
|
|
2020
Q4 | $652K | Buy |
+3,863
| New | +$577K | 0.05% | 163 |
|
|
2017
Q3 | – | Sell |
-2,893
| Closed | -$238K | – | 207 |
|
|
2017
Q2 | $238K | Hold |
2,893
| – | – | 0.03% | 191 |
|
|
2017
Q1 | $243K | Sell |
2,893
-208
| -7% | -$16.7K | 0.03% | 192 |
|
|
2016
Q4 | $228K | Hold |
3,101
| – | – | 0.03% | 192 |
|
|
2016
Q3 | $249K | Hold |
3,101
| – | – | 0.03% | 186 |
|
|
2016
Q2 | $244K | Sell |
3,101
-900
| -22% | -$67.8K | 0.03% | 187 |
|
|
2016
Q1 | $288K | Hold |
4,001
| – | – | 0.04% | 179 |
|
|
2015
Q4 | $337K | Sell |
4,001
-25
| -0.6% | -$2.08K | 0.04% | 162 |
|
|
2015
Q3 | $337K | Buy |
4,026
+25
| +0.6% | +$2.11K | 0.05% | 161 |
|
|
2015
Q2 | $334K | Buy |
4,001
+400
| +11% | +$30.5K | 0.04% | 162 |
|
|
2015
Q1 | $262K | Hold |
3,601
| – | – | 0.03% | 177 |
|
|
2014
Q4 | $248K | Hold |
3,601
| – | – | 0.03% | 183 |
|
|
2014
Q3 | $234K | Hold |
3,601
| – | – | 0.03% | 184 |
|
|
2014
Q2 | $224K | Hold |
3,601
| – | – | 0.03% | 189 |
|
|
2014
Q1 | $212K | Buy |
+3,601
| New | +$201K | 0.03% | 193 |
|
Other funds holding LLY
VCM
VPM
Tower Bridge Advisors's LLY Position: Q1 2026 in Review
Tower Bridge Advisors reduced its Eli Lilly (LLY) stake by 0.15% in Q1 2026, selling an estimated $10.1K and leaving 6,681 shares worth $6.14M. The position accounts for 0.59% of the portfolio, ranked #52.
Tower Bridge Advisors first reported a position in LLY in Q1 2014 and has held it in 36 quarters since. The position peaked at $8.11M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Tower Bridge Advisors held 6,681 shares of Eli Lilly worth $6.14M as of Q1 2026.
- Tower Bridge Advisors sold 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
- Eli Lilly made up 0.59% of Tower Bridge Advisors's portfolio in Q1 2026, its #52 holding.
- Tower Bridge Advisors first reported a position in Eli Lilly in Q1 2014 and has held it in 36 quarters since.
- Tower Bridge Advisors's Eli Lilly position peaked at $8.11M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.